104 related articles for article (PubMed ID: 38960464)
1. Segmentectomy for ground glass-dominant invasive lung cancer with tumour diameter of 2-3 cm: protocol for a single-arm, multicentre, phase III trial (ECTOP1012).
Chen S; Huang Q; Fu F; Wang Z; Zhang Y; Chen H
BMJ Open; 2024 Jul; 14(7):e087088. PubMed ID: 38960464
[TBL] [Abstract][Full Text] [Related]
2. Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial.
Aokage K; Suzuki K; Saji H; Wakabayashi M; Kataoka T; Sekino Y; Fukuda H; Endo M; Hattori A; Mimae T; Miyoshi T; Isaka M; Yoshioka H; Nakajima R; Nakagawa K; Okami J; Ito H; Kuroda H; Tsuboi M; Okumura N; Takahama M; Ohde Y; Aoki T; Tsutani Y; Okada M; Watanabe SI;
Lancet Respir Med; 2023 Jun; 11(6):540-549. PubMed ID: 36893780
[TBL] [Abstract][Full Text] [Related]
3. A non-randomized confirmatory trial of segmentectomy for clinical T1N0 lung cancer with dominant ground glass opacity based on thin-section computed tomography (JCOG1211).
Aokage K; Saji H; Suzuki K; Mizutani T; Katayama H; Shibata T; Watanabe S; Asamura H;
Gen Thorac Cardiovasc Surg; 2017 May; 65(5):267-272. PubMed ID: 28255781
[TBL] [Abstract][Full Text] [Related]
4. Ground glass opacity resection extent assessment trial
Li H; Wang Y; Chen Y; Zhong C; Fang W
Front Oncol; 2023; 13():1052796. PubMed ID: 36741022
[TBL] [Abstract][Full Text] [Related]
5. Comparison of surgical outcomes and prognosis between wedge resection and simple Segmentectomy for GGO diameter between 2 cm and 3 cm in non-small cell lung cancer: a multicenter and propensity score matching analysis.
Zhou Y; Yu T; Zhang Y; Qian L; Xia Q
BMC Cancer; 2022 Jan; 22(1):71. PubMed ID: 35034626
[TBL] [Abstract][Full Text] [Related]
6. [Clinical Efficacy Analysis of Wedge Resection of Pulmonary
in Patients with Small Volume Invasive Lung Adenocarcinoma].
Cui S; Wang G; Huang Z; Wu M; Wu H; Zhou H; Xu M; Xie M
Zhongguo Fei Ai Za Zhi; 2024 May; 27(5):359-366. PubMed ID: 38880923
[TBL] [Abstract][Full Text] [Related]
7. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
[TBL] [Abstract][Full Text] [Related]
8. Surgical outcome of wide wedge resection in poor-risk patients with clinical-N0 non-small cell lung cancer.
Tsunezuka H; Kato D; Okada S; Furuya T; Shimada J; Inoue M
Gen Thorac Cardiovasc Surg; 2017 Oct; 65(10):581-586. PubMed ID: 28748318
[TBL] [Abstract][Full Text] [Related]
9. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
Chest; 2014 Jan; 145(1):66-71. PubMed ID: 24551879
[TBL] [Abstract][Full Text] [Related]
10. A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer.
Suzuki K; Watanabe SI; Wakabayashi M; Saji H; Aokage K; Moriya Y; Yoshino I; Tsuboi M; Nakamura S; Nakamura K; Mitsudomi T; Asamura H;
J Thorac Cardiovasc Surg; 2022 Jan; 163(1):289-301.e2. PubMed ID: 33487427
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal patient-reported outcomes 1 year after thoracoscopic segmentectomy versus lobectomy for early-stage lung cancer: a multicentre, prospective cohort study protocol.
Gao X; Dai W; Zhang Q; Liu W; Liu Y; Yang L; Wei X; Shi Q; Pompili C; Pu Y; Xie S; Xiang R; Tian B; Hu B; Yang X; Wang X; Yang X; Xie T; Tang Y; Qiao G; Sun N; Gao S; Zhang G; Chen D; Cui Y; Chen X; He Y; Zhang R; Li Q; Zhuang X
BMJ Open; 2023 Jan; 13(1):e067841. PubMed ID: 36657755
[TBL] [Abstract][Full Text] [Related]
12. Segmentectomy for clinical stage IA lung adenocarcinoma showing solid dominance on radiology.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
Eur J Cardiothorac Surg; 2014 Oct; 46(4):637-42. PubMed ID: 24477740
[TBL] [Abstract][Full Text] [Related]
13. A Multi-Institutional, Randomized, Phase III Trial Comparing Anatomical Segmentectomy and Lobectomy for Clinical Stage IA3 Pure-Solid Non-Small-Cell Lung Cancer: West Japan Oncology Group Study WJOG16923L (STEP UP Trial).
Kamigaichi A; Hamada A; Tsuboi M; Yoshimura K; Okamoto I; Yamamoto N; Tsutani Y
Clin Lung Cancer; 2024 Jun; 25(4):384-388.e1. PubMed ID: 38360496
[TBL] [Abstract][Full Text] [Related]
14. Limited resection trial for pulmonary ground-glass opacity nodules: case selection based on high-resolution computed tomography-interim results.
Yoshida J; Ishii G; Hishida T; Aokage K; Tsuboi M; Ito H; Yokose T; Nakayama H; Yamada K; Nagai K
Jpn J Clin Oncol; 2015 Jul; 45(7):677-81. PubMed ID: 25900903
[TBL] [Abstract][Full Text] [Related]
15. Segmentectomy vs Lobectomy for Clinical Stage IA Lung Adenocarcinoma With Spread Through Air Spaces.
Kagimoto A; Tsutani Y; Kushitani K; Kai Y; Kambara T; Miyata Y; Takeshima Y; Okada M
Ann Thorac Surg; 2021 Sep; 112(3):935-943. PubMed ID: 33144104
[TBL] [Abstract][Full Text] [Related]
16. Surgical Outcomes of Lobectomy Versus Limited Resection for Clinical Stage I Ground-Glass Opacity Lung Adenocarcinoma 2 Centimeters or Smaller.
Zhang C; He Z; Cheng J; Cao J; Hu J
Clin Lung Cancer; 2021 Mar; 22(2):e160-e168. PubMed ID: 33160898
[TBL] [Abstract][Full Text] [Related]
17. Postoperative Recurrence and Survival After Segmentectomy for Clinical Stage 0 or IA Lung Cancer.
Kamigaichi A; Tsutani Y; Fujiwara M; Mimae T; Miyata Y; Okada M
Clin Lung Cancer; 2019 Sep; 20(5):397-403.e1. PubMed ID: 31281050
[TBL] [Abstract][Full Text] [Related]
18. [JCOG lung cancer surgery trial series: review and interpretation].
Li RZ; Qiu B
Zhonghua Zhong Liu Za Zhi; 2022 Jul; 44(7):703-711. PubMed ID: 35880335
[TBL] [Abstract][Full Text] [Related]
19. Protocol for the VAL-MAP 2.0 trial: a multicentre, single-arm, phase III trial to evaluate the effectiveness of virtual-assisted lung mapping by bronchoscopic dye injection and microcoil implementation in patients with small pulmonary nodules in Japan.
Ueda K; Uemura Y; Sato M
BMJ Open; 2019 Sep; 9(9):e028018. PubMed ID: 31488472
[TBL] [Abstract][Full Text] [Related]
20. Lung Adenocarcinoma Invasiveness Risk in Pure Ground-Glass Opacity Lung Nodules Smaller than 2 cm.
Lee GD; Park CH; Park HS; Byun MK; Lee IJ; Kim TH; Lee S
Thorac Cardiovasc Surg; 2019 Jun; 67(4):321-328. PubMed ID: 29359309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
